KRT6A Promotes Lung Cancer Cell Growth and Invasion Through MYC-Regulated Pentose Phosphate Pathway

• Published in: Frontiers in cell and developmental biology Vol. 9; p. 694071
• Main Authors: Che, Di, Wang, Mingshuo, Sun, Juan, Li, Bo, Xu, Tao, Lu, Yuxiong, Pan, Haiyan, Lu, Zhaoliang, Gu, Xiaoqiong
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 21-06-2021
• Subjects: Cell and Developmental Biology; G6PD; KRT6A; LSD1; MYC; NSCLC
• ISSN: 2296-634X; 2296-634X
• DOI: 10.3389/fcell.2021.694071

Keratin 6A (KRT6A) belongs to the keratin protein family which is a critical component of cytoskeleton in mammalian cells. Although KRT6A upregulation in non-small cell lung cancer (NSCLC) has been reported, the regulatory mechanism and functional role of KRT6A in NSCLC development have been less well investigated. In this study, KRT6A was confirmed to be highly expressed in NSCLC tissue samples, and its high expression correlated with poor patient prognosis. Furthermore, overexpression of KRT6A promotes NSCLC cell proliferation and invasion. Mechanistically, KRT6A overexpression is sufficient to upregulate glucose-6-phosphate dehydrogenase (G6PD) levels and increase the pentose phosphate pathway flux, an essential metabolic pathway to support cancer cell growth and invasion. In addition, we discovered that lysine-specific demethylase 1A (LSD1) functions upstream to promote KRT6A gene expression. We also found that the MYC family members c-MYC/MYCN are involved in KRT6A-induced G6PD upregulation. Therefore, this study reveals an underappreciated mechanism that KRT6A acts downstream of LSD1 and functions as a pivotal driver for NSCLC progression by upregulating G6PD through the MYC signaling pathway. Together, KRT6A and LSD1 may serve as potential prognostic indictors and therapeutic targets for NSCLC.